Taxus Baccata

by | Mar 15, 2018 | Taxus Baccata

How Can We Help?
You are here:
< Back

AM-2232 (1-(4-cyanobutyl)-3-(naphthalen-1-oyl)indole) is a drug that acts as a potent but unselective agonist for the cannabinoid receptors, with a Ki of 0.28 nM at CB1 and 1.48 nM at CB2.[1]

In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as AM-2232 are Schedule I Controlled Substances.[2]

See also

References

  1. ^ US patent 7241799, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2007-07-10 
  2. ^ 21 U.S.C. § 812: Schedules of controlled substances


Categories
Table of Contents